Matthew Fust
Direktor/Vorstandsmitglied bei ULTRAGENYX PHARMACEUTICAL INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Matthew Fust
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Direktor/Vorstandsmitglied | 01.01.2014 | - |
| Independent Dir/Board Member | 01.01.2014 | - | |
| ATARA BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.03.2014 | - |
| Independent Dir/Board Member | 01.03.2014 | - | |
| CRINETICS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.02.2018 | - |
| Independent Dir/Board Member | 01.02.2018 | - | |
| NEUMORA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.12.2020 | - |
| Independent Dir/Board Member | 01.12.2020 | - | |
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Arsenal Biosciences, Inc. discovers, develops, and commercializes curative immune cell therapies. It offers cell therapy, cloud computing, computational biology, genome engineering, machine learning, software engineering, and synthetic immunology. The company was founded by Ken E. Drazan, Bradley E. Bernstein, W. Nicholas Haining, Theo Roth, Kole T. Roybal, and E. John Wherry and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 08.03.2021 | - |
Karriereverlauf von Matthew Fust
Ehemalige bekannte Positionen von Matthew Fust
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 01.08.2017 | 01.06.2020 |
| MACROGENICS, INC. | Direktor/Vorstandsmitglied | 06.03.2014 | 14.05.2020 |
| Independent Dir/Board Member | 06.03.2014 | 14.05.2020 | |
| DERMIRA, INC. | Direktor/Vorstandsmitglied | 01.04.2014 | 20.02.2020 |
| Independent Dir/Board Member | 01.04.2014 | 20.02.2020 | |
| VIRACTA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.05.2005 | 01.01.2017 |
| Independent Dir/Board Member | 15.11.2011 | 01.01.2017 | |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Matthew Fust
| University of Minnesota | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 17 |
Operativ
| Director/Board Member | 9 |
| Independent Dir/Board Member | 7 |
| Director of Finance/CFO | 4 |
Sektoral
| Health Technology | 12 |
| Consumer Services | 4 |
| Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| MACROGENICS, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Retail Trade |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Anderson Consulting Team
 Anderson Consulting Team Movies/EntertainmentConsumer Services Part of HOK Group, Inc., Anderson Consulting Team is an American company that provides event planning services. The private company is based in MO. Anderson Consulting Team was acquired by Populous, Inc. on November 22, 2002. | Consumer Services |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Health Technology |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Arsenal Biosciences, Inc. discovers, develops, and commercializes curative immune cell therapies. It offers cell therapy, cloud computing, computational biology, genome engineering, machine learning, software engineering, and synthetic immunology. The company was founded by Ken E. Drazan, Bradley E. Bernstein, W. Nicholas Haining, Theo Roth, Kole T. Roybal, and E. John Wherry and is headquartered in San Francisco, CA. | Technology Services |
- Börse
- Insiders
- Matthew Fust
- Erfahrung
